Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence.

To analyze candidate genes and establish complex genotype-phenotype relationships against a background of high natural genome sequence variability, we have developed approaches to (i) compare candidate gene sequence information in multiple individuals; (ii) predict haplotypes from numerous variants; and (iii) classify haplotypes and identify specific sequence variants, or combinations of variants (pattern), associated with the phenotype. Using the human mu opioid receptor gene (OPRM1) as a model system, we have combined these approaches to test a potential role of OPRM1 in substance (heroin/cocaine) dependence. All known functionally relevant regions of this prime candidate gene were analyzed by multiplex sequence comparison in 250 cases and controls; 43 variants were identified and 52 different haplotypes predicted in the subgroup of 172 African-Americans. These haplotypes were classified by similarity clustering into two functionally related categories, one of which was significantly more frequent in substance-dependent individuals. Common to this category was a characteristic pattern of sequence variants [-1793T-->A, -1699Tins, -1320A-->G, -111C-->T, +17C-->T (A6V)], which was associated with substance dependence. This study provides an example of approaches that have been successfully applied to the establishment of complex genotype-phenotype relationships in the presence of abundant DNA sequence variation.

[1]  Francis S. Collins,et al.  Variations on a Theme: Cataloging Human DNA Sequence Variation , 1997, Science.

[2]  W. Berrettini,et al.  Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans , 1996, Biological Psychiatry.

[3]  S. Tavaré,et al.  Polymorphisms in the human DNA repair gene XPF. , 1999, Mutation research.

[4]  C R Scriver,et al.  Mutation nomenclature: Nicknames, systematic names, and unique identifiers , 1996, Human mutation.

[5]  J. Volpicelli,et al.  Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence , 1997, Psychopharmacology.

[6]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[7]  R. Evie Opioids: first lessons from knockout mice , 1999 .

[8]  G. De Soete,et al.  Clustering and Classification , 2019, Data-Driven Science and Engineering.

[9]  S. Antonarakis Recommendations for a nomenclature system for human gene mutations , 1998 .

[10]  H. Schulman,et al.  The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  G. Church,et al.  Multiplex DNA sequencing. , 1988, Science.

[12]  P. Richterich,et al.  DNA sequencing with direct transfer electrophoresis and nonradioactive detection. , 1993, Methods in enzymology.

[13]  M. Rieder,et al.  Sequence variation in the human angiotensin converting enzyme , 1999, Nature Genetics.

[14]  Robert F. Dannals,et al.  Increased mu opioid receptor binding detected by PET in cocaine–dependent men is associated with cocaine craving , 1996, Nature Medicine.

[15]  K. Kidd,et al.  HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes. , 1995, The Journal of heredity.

[16]  Cyrus R. Mehta,et al.  A hybrid algorithm for fisher's exact test in unordered rxc contingency tables , 1986 .

[17]  J. Witte,et al.  Genetic dissection of complex traits , 1996, Nature Genetics.

[18]  A. Templeton Cladistic approaches to identifying determinants of variability in multifactorial phenotypes and the evolutionary significance of variation in the human genome. , 2007, Ciba Foundation symposium.

[19]  S. Delbrück,et al.  A novel allelic variant of the human serotonin transporter gene regulatory polymorphism. , 1997, Cytogenetics and cell genetics.

[20]  C. Sing,et al.  A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. , 1992, Genetics.

[21]  Phipps Arabie,et al.  AN OVERVIEW OF COMBINATORIAL DATA ANALYSIS , 1996 .

[22]  A. Chakravarti It's raining SNPs, hallelujah? , 1998, Nature Genetics.

[23]  I. Sora,et al.  The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Nitin R. Patel,et al.  A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables , 1983 .

[25]  T. Wienker,et al.  Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. , 1998, Kidney international.

[26]  Brigitte L. Kieffer,et al.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene , 1996, Nature.

[27]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[28]  A. Hajeer The Genetic Variation and Human Disease: Principles and Evolutionary Approaches , 1996 .

[29]  K. Kidd,et al.  Population frequencies of the A1 allele at the dopamine D2 receptor locus , 1993, Biological Psychiatry.

[30]  M. Hasegawa,et al.  Relative efficiencies of the maximum likelihood, maximum parsimony, and neighbor-joining methods for estimating protein phylogeny. , 1993, Molecular phylogenetics and evolution.

[31]  S. Tishkoff,et al.  Global Patterns of Linkage Disequilibrium at the CD4 Locus and Modern Human Origins , 1996, Science.

[32]  J A Tischfield,et al.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[34]  G. Carey Genetic association study in psychiatry: analytical evaluation and a recommendation. , 1994, American journal of medical genetics.

[35]  Francis S. Collins,et al.  Positional cloning moves from perditional to traditional , 1995, Nature Genetics.

[36]  W. Vogel,et al.  Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains , 1994, Nature Genetics.

[37]  E. Boerwinkle,et al.  Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. , 1998, American journal of human genetics.

[38]  Update on nomenclature for human gene mutations. Ad Hoc Committee on Mutation Nomenclature. , 1996, Human mutation.

[39]  G. Uhl,et al.  Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. , 1994, FEBS letters.

[40]  E. Boerwinkle,et al.  A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. , 1987, Genetics.

[41]  E. Boerwinkle,et al.  DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene , 1998, Nature Genetics.

[42]  James R. Eshleman,et al.  Conversion of diploidy to haploidy , 2000, Nature.

[43]  E. Ochoa Mangado [Naltrexone in the treatment of alcohol dependence]. , 1998, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines.

[44]  E. Brody,et al.  An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken beta-tropomyosin pre-mRNA. , 1995, Nucleic acids research.

[45]  E. Lander,et al.  Genetic dissection of complex traits science , 1994 .

[46]  Wilkie,et al.  Genetics of disease. , 1996, Current opinion in genetics & development.

[47]  Nitin R. Patel,et al.  ALGORITHM 643: FEXACT: a FORTRAN subroutine for Fisher's exact test on unordered r×c contingency tables , 1986, TOMS.

[48]  M. Kreek Opiates, opioids and addiction. , 1996, Molecular psychiatry.

[49]  K. Kidd,et al.  Associations of disease with genetic markers: déjà vu all over again. , 1993, American journal of medical genetics.

[50]  M. Smolka,et al.  Human μ‐Opioid Receptor Variation and Alcohol Dependence , 1998 .

[51]  W. Berrettini,et al.  Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse , 1997, Addiction biology.

[52]  J. Nurnberger,et al.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. , 1991, Nucleic acids research.

[53]  A. Valdés,et al.  Detecting disease-predisposing variants: the haplotype method. , 1997, American journal of human genetics.

[54]  M. Hoehe,et al.  The human µ opioid receptor gene: 5´ regulatory and intronic sequences , 1998, Journal of Molecular Medicine.

[55]  J. Long,et al.  μ opioid receptor gene variants: lack of association with alcohol dependence , 1997, Molecular Psychiatry.

[56]  A. Herz Endogenous opioid systems and alcohol addiction , 1997, Psychopharmacology.

[57]  K. Weiss Is there a paradigm shift in genetics? Lessons from the study of human diseases. , 1996, Molecular phylogenetics and evolution.

[58]  N. Schork,et al.  Issues and strategies in the genetic analysis of alcoholism and related addictive behaviors. , 1998, Alcohol.

[59]  Alan Agresti,et al.  Exact Inference for Contingency Tables with Ordered Categories , 1990 .

[60]  E. Lander The New Genomics: Global Views of Biology , 1996, Science.

[61]  A. Templeton,et al.  A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apoprotein E locus. , 1995, Genetics.

[62]  T. Duka,et al.  Dose-dependent influence of Fentanyl on prolactin, growth hormone, and mood , 1984, Neuropeptides.

[63]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[64]  G. Golden,et al.  The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice. , 1997, Life sciences.

[65]  M. Nei Molecular Evolutionary Genetics , 1987 .

[66]  J. Terwilliger Genetic Variation and Human Disease: Principles and Evolutionary Approaches , 1997 .

[67]  K. Weiss,et al.  Linkage disequilibrium mapping of complex disease: fantasy or reality? , 1998, Current opinion in biotechnology.

[68]  Y. Koda,et al.  Allelic diversity of the human plasma α(1,3)fucosyltransferase gene (FUT6) , 1999 .

[69]  C. Mazure,et al.  Blindness and reliability in lifetime psychiatric diagnosis. , 1979, Archives of general psychiatry.